ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

The SOS1 Inhibitor BI 1701963 as Monotherapy or in Combination with Trametinib in Patients with KRAS Mutation-Positive Solid Tumors.

Pasi A Jänne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.